Compound
← Compound
Official website →
HLNHaleon plc
Quotes delayed by up to 15 minutes · informational, not investment advice
Escopo e origem dos dados
- Ativo
- HLN
- Moeda das demonstrações
- GBP
- Último período anual nesta tabela
- 2025-12-31
- Fonte das demonstrações
- SEC EDGAR
Data de demonstração não é horário de cotação. Dado ausente não é zero. A cobertura varia por ativo e fonte; confira o documento original antes de interpretar um número.
Fontes e metodologiaAbout the company
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, a…
IndustryDrug Manufacturers - Specialty & Generic
Smart calendar
Organizing upcoming events...
Key metrics
What the market pays
P/E
Price divided by trailing 12-month earnings
18.7×
P/B
Price divided by book value
1.85×
EV/EBITDA
Enterprise value divided by operating cash generation
13.06×
EV/Revenue
Enterprise value divided by revenue
3.35×
What the company earns
ROE
Return on shareholders’ equity
9.9%
ROA
Return on all assets
5%
Gross margin
What remains after product costs
65.6%
Operating margin
What remains after operating the business
21.4%
Net margin
How much of each revenue unit becomes profit
14.6%
What it owes
Debt / Equity
Debt for each unit of shareholders’ equity
0.5
Total debt
Sum of borrowings
£8.2B
Cash
Cash available to cover it
£821.01M
Current ratio
Short-term assets divided by short-term liabilities
0.69
Free cash flow
Cash left after investing
£791.8M
Risk and growth
Beta
Moves more (>1) or less (<1) than the market
0.25
Revenue growth
Compared with the same period a year earlier
3%
Earnings growth
Compared with the same period a year earlier
-4.8%
Dividend yield
Trailing 12-month distributions divided by price
2.2%
Market data provider figures for the latest published period. Informational, not investment advice.
Financial statements(GBP)
Income statement
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Receita | 10.86B | 11.3B | 11.23B | 11.03B |
| Custo dos produtos | -4.28B | -4.56B | -4.41B | -3.95B |
| Lucro bruto | 6.58B | 6.75B | 6.82B | 7.08B |
| Pesquisa e desenvolvimento | -300M |
News about HLN
Seeking Alpha · 5 days ago
Haleon takes advantage of GLP-1 side effects as US sales rise
Follow HLN and get agent analysis of what is moving the stock.
Open Compound